- Report
- April 2023
- 180 Pages
Global
From €2885EUR$3,000USD£2,475GBP
- Report
- April 2023
- 137 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- September 2022
- 282 Pages
Global
From €9135EUR$9,500USD£7,836GBP
- Report
- August 2022
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Report
- February 2022
- 210 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- April 2023
- 115 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- May 2023
- 450 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Report
- February 2022
- 228 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- January 2022
- 60 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Report
- December 2022
- 116 Pages
Global
From €4712EUR$4,900USD£4,042GBP
The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more